-
1761por Kim, Hye-Yeong, Wang, Xiaolei, Kang, Rui, Tang, Daolin, Boone, Brian A., Zeh, Herbert J., Lotze, Michael T., Edwards, W. Barry“…An in vivo biodistribution study was performed with the (64)Cu-radiolabled scFv in a syngeneic murine pancreatic cancer model, demonstrating both the feasibility and potential of an anti-RAGE scFv for detection of PDAC. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1762por Nogueira, Sara Tavares, Pinto, Bruno Lima, Silva, Eduardo Faria, Garcia, Hermano Anjos, Carneiro, Francisco“…INTRODUCTION: Pancreatic cancer is the fourth major cause of cancer-related deaths. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1763por Dalah, Entesar, Erickson, Beth, Oshima, Kiyoko, Schott, Diane, Hall, William A., Paulson, Eric, Tai, An, Knechtges, Paul, Li, X. AllenEnlace del recurso
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1764“…Pancreatic cancer is one of the most lethal malignancies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1765
-
1766por Shirai, Yoshihiro, Saito, Nobuhiro, Uwagawa, Tadashi, Shiba, Hiroaki, Horiuchi, Takashi, Iwase, Ryota, Haruki, Koichiro, Ohashi, Toya, Yanaga, Katsuhiko“…We hypothesized that pomalidomide may inhibit the anticancer agent-induced NF-κB activity and enhance chemosensitization of combination chemotherapy with gemcitabine and S1 (Gem/S1) in pancreatic cancer. METHODS: In vitro, we assessed NF-κB activity, induction of caspase cascade, cell apoptosis and cell proliferation using human pancreatic cancer cell lines (MIA PaCa-2 and PANC-1). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1767
-
1768“…5-FU chemotherapy is a current strategy to treat pancreatic cancer (PC), but unfortunately chemoresistance is eventually developed in most patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1769por Kondo, Yasuyuki, Chung, Yong‐Suk, Sawada, Tetsuji, Inui, Akimasa, Yamashita, Yoshito, Hirayama, Koji, Nakata, Bunzo, Ho, Jenny J. L., Kim, Young S., Sowa, MichioEnlace del recurso
Publicado 1995
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1770por Gotoda, Takuji, Matsumura, Yasuhiro, Kondo, Hitoshi, Saitoh, Daizo, Shimada, Yasuhiro, Kosuge, Tomoo, Kanai, Yae, Kakizoe, Tadao“…Since the CD44 variant 6(v6) molecule has been noted as a marker for tumor metastasis and prognosis in several tumors, we examined whether or not v6 is a useful marker for evaluating the prognosis of pancreatic cancer patients. In addition, we attempted to assess the clinicopathological implications for pancreatic cancer of the variant 2 (v2) isoform using a recently developed monoclonal antibody against a v2 epitope. …”
Publicado 1998
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1771por Manegold, Philipp, Lai, Keane K. Y., Wu, Yongfeng, Teo, Jia-Ling, Lenz, Heinz-Josef, Genyk, Yuri S., Pandol, Stephen J., Wu, Kaijin, Lin, David P., Chen, Yibu, Nguyen, Cu, Zhao, Yi, Kahn, Michael“…Results/conclusion: We report for the first time that K-Ras activation increases the CBP/β-catenin interaction in pancreatic cancer; and that ICG-001 specific antagonism of the CBP/β-catenin interaction sensitizes pancreatic cancer cells and tumors to gemcitabine treatment. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1772
-
1773por Yu, Da-Young, Yu, Young-Dong, Kim, Wan-Bae, Han, Hyung-Joon, Choi, Sae-Byul, Kim, Dong-Sik, Choi, Sang-Yong, Kim, Joo-Young, Chang, Hyeyoon, Kim, Baek-Hui“…CONCLUSION: The presence or absence of PanIN lesions did not affect survival in patients undergoing resection for pancreatic cancer. However, patients with high-grade PanINs tended to have better overall survival. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1774por Huang, Joyce Y., Butler, Lesley M., Midttun, Øivind, Ulvik, Arve, Wang, Renwei, Jin, Aizhen, Gao, Yu-Tang, Ueland, Per M., Koh, Woon-Puay, Yuan, Jian-Min“…BACKGROUND: Serum pyridoxal 5’-phosphate (PLP), the active form of vitamin B(6), is associated with reduced risk of pancreatic cancer. Data on functional measures of vitamin B(6) status and risk of pancreatic cancer is lacking. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1775“…BACKGROUND: Pancreatic cancer (PC) is a deadly disease with poor prognosis in the general population. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1776por Cho, Chang MinEnlace del recurso
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1777por Chen, Xiao, Zhou, Hao, Li, Xiaoshuang, Duan, Na, Hu, Shouyou, Liu, Yongkang, Yue, Yali, Song, Lina, Zhang, Yifen, Li, Donghui, Wang, Zhongqiu“…BACKGROUND: Biomarker-targeted molecular imaging holds promise for early detection of pancreatic cancer. The aim of this study was to design and evaluate a plectin-1 targeted multi-functional nanoparticle probe for pancreatic cancer imaging. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1778por Seoane-Mato, Daniel, Nuñez, Olivier, Fernández-de-Larrea, Nerea, Pérez-Gómez, Beatriz, Pollán, Marina, López-Abente, Gonzalo, Aragonés, Nuria“…BACKGROUND: Pancreatic cancer is acquiring increasing prominence as a cause of cancer death in the population. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1779por Martín, Andrés Muñoz, Hidalgo, Manuel, Alvarez, Rafael, Arrazubi, Virginia, Martínez-Galán, Joaquina, Salgado, Mercedes, Macarulla, Teresa, Carrato, AlfredoEnlace del recurso
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1780por Lu, Ran, Yang, Jin, Wei, Rui, Ke, Jing, Tian, Qing, Yu, Fei, Liu, Junling, Zhang, Jingjing, Hong, Tianpei“…Either metformin or liraglutide has been reported to have anti-tumor effects on pancreatic cancer cells. However, it is not clear whether their combined treatment has additive or synergistic anti-tumor effects on pancreatic cancer cells. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto